‘Amityville Horror’ killer Ronald DeFeo dies in prison at 69
“Amityville Horror” killer Ronald DeFeo — who killed his six family members in 1974 on Long Island — has died behind bars, according to officials.
Washington Post panned for massive correction to Trump-Georgia election story: ‘So, they made up quotes’
The Washington Post made a massive correction Monday to a January report about a phone call between then-President Donald Trump and Georgia elections investigator Frances Watson, admitting it wrongly…
US to house up to 3,000 immigrant teens at Dallas convention center
DALLAS (AP) — The U.S. government plans to use the downtown Dallas convention center to hold up to 3,000 immigrant teenagers as sharply higher numbers of border crossings…
Crowds of people swarm Las Vegas Strip days before capacity limits ease
Various videos on Tiktok showed crowds of people shoulder to shoulder.
Psaki acknowledges ‘big problem’ at border, blames Trump administration
White House press secretary Jen Psaki on Monday referred to the influx of migrants at the southern border as a “big problem” and blamed the Trump administration for…
Test drive: The Mercedes E 450 4MATIC All-Terrain is a short utility vehicle
The 2021 Mercedes-Benz E 450 All-Terrain is a low-roof alternative to the automaker’s large lineup of SUVs.
Rep. Chuck Fleischmann: Fixing Biden’s border crisis – it’s time for Dems to work with GOP on a solution
The Biden administration is clearly overwhelmed by the situation on our southern border and lacks a substantive plan to deal with it.
CNN asks whether Abraham Lincoln believed Black lives mattered
Abraham Lincoln might have cared about Black people, according to CNN.
Germany suspends AstraZeneca COVID-19 vaccinations amid blood clotting reports
Germany joined an expanding list of several EU countries to suspend AstraZeneca COVID-19 vaccinations amid concerns of blood clotting in vaccinated individuals, with Health Minister Jens Spahn calling the…
Moderna’s next generation COVID-19 vaccine candidate tested in clinical trial participants
Moderna on Monday announced that it began administering its next generation COVID-19 vaccine candidate in a Phase 1 study.